Package 67046-1613-3

{"route": ["ORAL"], "spl_id": "48c0ccac-2fe3-0fe2-e063-6294a90a2a9c", "openfda": {"nui": ["N0000175462", "N0000009947"], "unii": ["4B9XT59T7S"], "rxcui": ["199663"], "spl_set_id": ["437f55b2-f6d9-0065-e063-6294a90ab929"], "pharm_class_epc": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Coupler LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BLISTER PACK (67046-1613-3)", "package_ndc": "67046-1613-3", "marketing_start_date": "20251113"}], "brand_name": "Zidovudine", "product_id": "67046-1613_48c0ccac-2fe3-0fe2-e063-6294a90a2a9c", "dosage_form": "TABLET", "pharm_class": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "67046-1613", "generic_name": "Zidovudine", "labeler_name": "Coupler LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Zidovudine", "active_ingredients": [{"name": "ZIDOVUDINE", "strength": "300 mg/1"}], "application_number": "ANDA090092", "marketing_category": "ANDA", "marketing_start_date": "20251113", "listing_expiration_date": "20271231"}